{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T01:34:00Z","timestamp":1791596040007,"version":"4.3.4"},"reference-count":41,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2018,10,25]],"date-time":"2018-10-25T00:00:00Z","timestamp":1540425600000},"content-version":"vor","delay-in-days":1,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006662","name":"NIHR","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006662","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Oxford Biomedical Research Centre"},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013373","name":"NIHR Oxford Biomedical Research Centre","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100013373","id-type":"DOI","asserted-by":"crossref"}]},{"name":"British Heart Foundation Clinical Research Training Fellowship","award":["098436\/Z\/12\/Z"],"award-info":[{"award-number":["098436\/Z\/12\/Z"]}]},{"DOI":"10.13039\/100006662","name":"NIHR","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006662","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000288","name":"Royal Society","doi-asserted-by":"publisher","award":["098436\/Z\/12\/B"],"award-info":[{"award-number":["098436\/Z\/12\/B"]}],"id":[{"id":"10.13039\/501100000288","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006662","name":"NIHR","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006662","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Barts Biomedical Research Centre"},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["WT098519MA"],"award-info":[{"award-number":["WT098519MA"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["FS\/18\/3\/33292"],"award-info":[{"award-number":["FS\/18\/3\/33292"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Oxford British Heart Foundation Center of Research Excellence"},{"name":"National Institute of Heath"},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["U01HL117006-01A1"],"award-info":[{"award-number":["U01HL117006-01A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,2,1]]},"DOI":"10.1093\/ehjci\/jey135","type":"journal-article","created":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T03:13:04Z","timestamp":1536203584000},"page":"157-167","source":"Crossref","is-referenced-by-count":137,"title":["Progression of myocardial fibrosis in hypertrophic cardiomyopathy: mechanisms and clinical implications"],"prefix":"10.1093","volume":"20","author":[{"given":"Betty","family":"Raman","sequence":"first","affiliation":[{"name":"Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, Headley Way, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rina","family":"Ariga","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, Headley Way, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Spartera","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, Headley Way, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Sivalokanathan","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, Headley Way, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Chan","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, Headley Way, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sairia","family":"Dass","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, Headley Way, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffen E","family":"Petersen","sequence":"additional","affiliation":[{"name":"William Harvey Research Institute, NIHR Barts Biomedical Research Centre, Queen Mary University of London, London, UK"},{"name":"Barts Heart Centre, St Bartholomew\u2019s hospital, Barts Health NHS Trust, West Smithfield, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J","family":"Daniels","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, Headley Way, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Francis","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, Headley Way, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Smillie","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, Headley Way, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam J","family":"Lewandowski","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, Headley Way, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric O","family":"Ohuma","sequence":"additional","affiliation":[{"name":"Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Centre for Statistics in Medicine, University of Oxford, Old Road Campus, Oxford, UK"},{"name":"Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Old Road Campus, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Rodgers","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, Headley Way, Oxford, UK"},{"name":"Department of Clinical Neurosciences, Wolfson Brain Imaging Centre, University of Cambridge, Cambridge, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher M","family":"Kramer","sequence":"additional","affiliation":[{"name":"Cardiology and Radiology, University of Virginia Health System, Charlottesville, VA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masliza","family":"Mahmod","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, Headley Way, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugh","family":"Watkins","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, Headley Way, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Neubauer","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, Headley Way, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,10,24]]},"reference":[{"key":"2019041301283592800_jey135-B1","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/S0735-1097(00)01003-2","article-title":"Sudden death in hypertrophic cardiomyopathy: identification of high risk patients","volume":"36","author":"Elliott","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"2019041301283592800_jey135-B2","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1093\/ehjci\/jes302","article-title":"Prediction of ventricular arrhythmias using cardiovascular magnetic resonance","volume":"14","author":"Mavrogeni","year":"2013","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2019041301283592800_jey135-B3","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0735-1097(99)00492-1","article-title":"Morphology and significance of the left ventricular collagen network in young patients with hypertrophic cardiomyopathy and sudden cardiac death","volume":"35","author":"Shirani","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"2019041301283592800_jey135-B4","doi-asserted-by":"crossref","first-page":"e003090","DOI":"10.1161\/CIRCHEARTFAILURE.116.003090","article-title":"Histological and histometric characterization of myocardial fibrosis in end-stage hypertrophic cardiomyopathy: a clinical-pathological study of 30 explanted hearts","volume":"9","author":"Galati","year":"2016","journal-title":"Circ Heart Fail"},{"key":"2019041301283592800_jey135-B5","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1080\/10976640600605002","article-title":"The histological basis of late gadolinium enhancement cardiovascular magnetic resonance in a patient with Anderson-Fabry disease","volume":"8","author":"Moon","year":"2006","journal-title":"J Cardiovasc Magn Reson"},{"key":"2019041301283592800_jey135-B6","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.jcmg.2012.09.018","article-title":"Myocardial fibrosis in hypertrophic cardiomyopathy: accurate reflection of histopathological findings by CMR","volume":"6","author":"Moravsky","year":"2013","journal-title":"JACC Cardiovasc Imaging"},{"key":"2019041301283592800_jey135-B7","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.jacc.2010.05.010","article-title":"Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy","volume":"56","author":"O'Hanlon","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"2019041301283592800_jey135-B8","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1161\/CIRCULATIONAHA.113.007094","article-title":"Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy","volume":"130","author":"Chan","year":"2014","journal-title":"Circulation"},{"key":"2019041301283592800_jey135-B9","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1161\/CIRCULATIONAHA.117.032966","article-title":"Prevalence and progression of late gadolinium enhancement in children and adolescents with hypertrophic cardiomyopathy","volume":"138","author":"Raja","year":"2018","journal-title":"Circulation"},{"key":"2019041301283592800_jey135-B10","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.jacc.2012.03.076","article-title":"Progression of myocardial fibrosis assessed with cardiac magnetic resonance in hypertrophic cardiomyopathy","volume":"60","author":"Todiere","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"2019041301283592800_jey135-B11","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1136\/heartjnl-2014-306555","article-title":"Myocardial fibrosis progression on cardiac magnetic resonance in hypertrophic cardiomyopathy","volume":"101","author":"Choi","year":"2015","journal-title":"Heart"},{"key":"2019041301283592800_jey135-B12","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s00259-009-1350-3","article-title":"Determinants of myocardial energetics and efficiency in symptomatic hypertrophic cardiomyopathy","volume":"37","author":"Timmer","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2019041301283592800_jey135-B13","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1016\/S0735-1097(02)03009-7","article-title":"Hypertrophic cardiomyopathy due to sarcomeric gene mutations is characterized by impaired energy metabolism irrespective of the degree of hypertrophy","volume":"41","author":"Crilley","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"2019041301283592800_jey135-B14","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.jacc.2005.10.050","article-title":"Relevance of coronary microvascular flow impairment to long-term remodeling and systolic dysfunction in hypertrophic cardiomyopathy","volume":"47","author":"Olivotto","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"2019041301283592800_jey135-B15","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1161\/CIRCULATIONAHA.109.934059","article-title":"Metabolic modulator perhexiline corrects energy deficiency and improves exercise capacity in symptomatic hypertrophic cardiomyopathy","volume":"122","author":"Abozguia","year":"2010","journal-title":"Circulation"},{"key":"2019041301283592800_jey135-B16","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1093\/eurheartj\/ehv120","article-title":"Exacerbation of cardiac energetic impairment during exercise in hypertrophic cardiomyopathy: a potential mechanism for diastolic dysfunction","volume":"36","author":"Dass","year":"2015","journal-title":"Eur Heart J"},{"key":"2019041301283592800_jey135-B17","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.jacc.2012.12.024","article-title":"Blunted myocardial oxygenation response during vasodilator stress in patients with hypertrophic cardiomyopathy","volume":"61","author":"Karamitsos","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2019041301283592800_jey135-B18","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1002\/jmri.21135","article-title":"Biochemical safety profiles of gadolinium-based extracellular contrast agents and nephrogenic systemic fibrosis","volume":"26","author":"Ersoy","year":"2007","journal-title":"J Magn Reson Imaging"},{"key":"2019041301283592800_jey135-B19","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00261-005-0380-y","article-title":"Esur. ESUR guidelines on contrast media","volume":"31","author":"Thomsen","year":"2006","journal-title":"Abdom Imaging"},{"key":"2019041301283592800_jey135-B20","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1093\/ndt\/gfk062","article-title":"Gadolinium\u2014a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?","volume":"21","author":"Grobner","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"2019041301283592800_jey135-B21","doi-asserted-by":"crossref","first-page":"3794","DOI":"10.1038\/s41598-017-03699-5","article-title":"Myocardial deformation in cardiac amyloid light-chain amyloidosis: assessed with 3T cardiovascular magnetic resonance feature tracking","volume":"7","author":"Li","year":"2017","journal-title":"Sci Rep"},{"key":"2019041301283592800_jey135-B22","doi-asserted-by":"crossref","first-page":"85.","DOI":"10.1186\/s12968-014-0085-x","article-title":"Accuracy and reproducibility of semi-automated late gadolinium enhancement quantification techniques in patients with hypertrophic cardiomyopathy","volume":"16","author":"Mikami","year":"2014","journal-title":"J Cardiovasc Magn Reson"},{"key":"2019041301283592800_jey135-B23","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","article-title":"2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC)","volume":"35","author":"Elliott","year":"2014","journal-title":"Eur Heart J"},{"key":"2019041301283592800_jey135-B24","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1177\/0272989X0102100106","article-title":"Prognostic modeling with logistic regression analysis: in search of a sensible strategy in small data sets","volume":"21","author":"Steyerberg","year":"2001","journal-title":"Med Decis Making"},{"key":"2019041301283592800_jey135-B25","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.jacc.2017.12.046","article-title":"Diagnosis of microvascular angina using cardiac magnetic resonance","volume":"71","author":"Liu","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2019041301283592800_jey135-B26","first-page":"78","article-title":"Cardiac magnetic resonance imaging for myocardial perfusion and diastolic function-reference control values for women","volume":"6","author":"Bakir","year":"2016","journal-title":"Cardiovasc Diagn Ther"},{"key":"2019041301283592800_jey135-B27","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1172\/JCI1940","article-title":"Diastolic dysfunction and altered energetics in the alphaMHC403\/+ mouse model of familial hypertrophic cardiomyopathy","volume":"101","author":"Spindler","year":"1998","journal-title":"J Clin Invest"},{"key":"2019041301283592800_jey135-B28","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1093\/eurheartj\/ehq136","article-title":"Clinicopathological profiles of progressive heart failure in hypertrophic cardiomyopathy","volume":"31","author":"Melacini","year":"2010","journal-title":"Eur Heart J"},{"key":"2019041301283592800_jey135-B29","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1136\/hrt.2004.041384","article-title":"Myocardial late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy caused by mutations in troponin I","volume":"91","author":"Moon","year":"2005","journal-title":"Heart"},{"key":"2019041301283592800_jey135-B30","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.jacc.2004.01.054","article-title":"Progressive left ventricular remodeling in patients with hypertrophic cardiomyopathy and severe left ventricular hypertrophy","volume":"44","author":"Thaman","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"2019041301283592800_jey135-B31","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1056\/NEJMoa1002659","article-title":"Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy","volume":"363","author":"Ho","year":"2010","journal-title":"N Engl J Med"},{"key":"2019041301283592800_jey135-B32","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.jacc.2011.05.018","article-title":"Microvascular function is selectively impaired in patients with hypertrophic cardiomyopathy and sarcomere myofilament gene mutations","volume":"58","author":"Olivotto","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"2019041301283592800_jey135-B33","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/0140-6736(93)92064-Z","article-title":"Angiotensin-converting enzyme polymorphism in hypertrophic cardiomyopathy and sudden cardiac death","volume":"342","author":"Marian","year":"1993","journal-title":"Lancet"},{"key":"2019041301283592800_jey135-B34","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/00001573-200205000-00006","article-title":"Modifier genes for hypertrophic cardiomyopathy","volume":"17","author":"Marian","year":"2002","journal-title":"Curr Opin Cardiol"},{"key":"2019041301283592800_jey135-B35","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1172\/JCI42028","article-title":"Cardiac fibrosis in mice with hypertrophic cardiomyopathy is mediated by non-myocyte proliferation and requires Tgf-beta","volume":"120","author":"Teekakirikul","year":"2010","journal-title":"J Clin Invest"},{"key":"2019041301283592800_jey135-B36","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1113\/expphysiol.2012.064709","article-title":"Investigating cardiac energetics in heart failure","volume":"98","author":"Lygate","year":"2013","journal-title":"Exp Physiol"},{"key":"2019041301283592800_jey135-B37","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1161\/CIRCULATIONAHA.106.657023","article-title":"Evidence for microvascular dysfunction in hypertrophic cardiomyopathy: new insights from multiparametric magnetic resonance imaging","volume":"115","author":"Petersen","year":"2007","journal-title":"Circulation"},{"key":"2019041301283592800_jey135-B38","doi-asserted-by":"crossref","first-page":"49.","DOI":"10.1186\/s12968-014-0049-1","article-title":"Coronary microvascular ischemia in hypertrophic cardiomyopathy\u2014a pixel-wise quantitative cardiovascular magnetic resonance perfusion study","volume":"16","author":"Ismail","year":"2014","journal-title":"J Cardiovasc Magn Reson"},{"key":"2019041301283592800_jey135-B39","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1136\/heartjnl-2011-300960","article-title":"Low-grade inflammation and the phenotypic expression of myocardial fibrosis in hypertrophic cardiomyopathy","volume":"98","author":"Kuusisto","year":"2012","journal-title":"Heart"},{"key":"2019041301283592800_jey135-B40","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ahj.2015.05.013","article-title":"Hypertrophic Cardiomyopathy Registry: the rationale and design of an international, observational study of hypertrophic cardiomyopathy","volume":"170","author":"Kramer","year":"2015","journal-title":"Am Heart J"},{"key":"2019041301283592800_jey135-B41","doi-asserted-by":"crossref","first-page":"e101465.","DOI":"10.1371\/journal.pone.0101465","article-title":"High sensitivity of late gadolinium enhancement for predicting microscopic myocardial scarring in biopsied specimens in hypertrophic cardiomyopathy","volume":"9","author":"Konno","year":"2014","journal-title":"PLoS One"}],"container-title":["European Heart Journal - Cardiovascular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ehjcimaging\/article-pdf\/20\/2\/157\/28377269\/jey135.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,20]],"date-time":"2020-05-20T02:23:36Z","timestamp":1589941416000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjcimaging\/article\/20\/2\/157\/5144422"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,24]]},"references-count":41,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2018,10,24]]},"published-print":{"date-parts":[[2019,2,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjci\/jey135","relation":{},"ISSN":["2047-2404","2047-2412"],"issn-type":[{"value":"2047-2404","type":"print"},{"value":"2047-2412","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,2]]},"published":{"date-parts":[[2018,10,24]]}}}